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Chondrodysplasia punctata (CDP) is an etiologically heterogenous condition caused by 
single gene disorders, chromosome abnormalities, maternal diseases or exposures to 
teratogens. We report a male fetus with rhizomelic CDP associated with deletion at 5q15-
5q21.1. This segment contains the DRAGON gene, a bone morphogenetic factor co-
receptor, also known as RGMb (repulsive guidance molecule b). It is postulated that its 
haplo-insufficiency is associated with the phenotype in this fetus. The mother (30yo, 
G2P0SA1L0) was referred at 19.3 weeks for abnormal antenatal ultrasound findings of 
short limbs, short splayed digits, brachycephaly, small cistern magna, hypoplastic inferior 
cerebellar vermis, micrognathia, multiple intracardiac echogenic foci and 2-vessel 
umbilical cord. There was no history of maternal disease/ exposures. The pregnancy was 
terminated at 21 weeks. Autopsy confirmed the ultrasound findings and in addition 
showed brain hypomyelination with ventriculomegaly. Biochemical studies revealed 
normal plasmalogen and cholesterol biosynthetic function. Radiograph showed numerous 
abnormal calcific stipplings and prematurely calcified ossification centers. There was 
rhizomelic shortening of proximal long bones, abnormal calcification/ossification in the 
cervical, thoracic and sacral spine and poorly formed with platyspondyly of the cervical 
and thoracic spine with thin ribs. The findings were in keeping with rhizomelic CPD. The 
Agilent 105K array (Signature Genomics) shows a de novo 3.4Mb deletion at 5q15-
5q21.1. The region does not contain any OMIM disease genes and has not been reported 
in the DECIPHER Initiative. It contains 3 genes including the DRAGON (RGMB) gene, 
which is of interest as its encoding protein is a bone morphogenetic protein (BMP) co-
receptor. BMPs induce ectopic bone and cartilage formation in experimental animals. 
They are important for skeletal patterning and are involved in the development of many 
tissues including bones, craniofacial structures and nervous system. As a co-receptor for 
BMPs, DRAGON is important in neural and neural crest patterning early in development. 
DRAGON is also found to be expressed in brachial arches, somites and the tail bud of 
developing mouse and Xenopus but its function in skeletal patterning is not well 
described. Since a copy of the DRAGON gene is deleted in our patient, we postulate that 
haplo-insufficiency of this gene is related to the pathogenesis of the CDP phenotype. 
